147 related articles for article (PubMed ID: 569889)
1. Methamphetamine-induced behavioural effects and brain concentrations of methamphetamine and its metabolite amphetamine in mice.
Brien JF; Kitney JC; Peachey JE; Rogers BJ
Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):313-28. PubMed ID: 569889
[TBL] [Abstract][Full Text] [Related]
2. Sex- and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in rats.
Milesi-Hallé A; Hendrickson HP; Laurenzana EM; Gentry WB; Owens SM
Toxicol Appl Pharmacol; 2005 Dec; 209(3):203-13. PubMed ID: 15916788
[TBL] [Abstract][Full Text] [Related]
3. Ginsenosides attenuate methamphetamine-induced behavioral side effects in mice via activation of adenosine A2A receptors: possible involvements of the striatal reduction in AP-1 DNA binding activity and proenkephalin gene expression.
Shin EJ; Nabeshima T; Suh HW; Jhoo WK; Oh KW; Lim YK; Kim DS; Choi KH; Kim HC
Behav Brain Res; 2005 Mar; 158(1):143-57. PubMed ID: 15680202
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine-induced behavioral effects and releases of brain catecholamines and brain concentrations of methamphetamine in mice.
Yamanaka Y; Yamamoto T; Egashira T
Jpn J Pharmacol; 1983 Feb; 33(1):33-40. PubMed ID: 6683768
[TBL] [Abstract][Full Text] [Related]
5. Brain excitatory amino acid transporters (EAATs) and treatment of methamphetamine toxicity.
Hayase T; Yamamoto Y; Yamamoto K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Dec; 38(6):498-511. PubMed ID: 14750360
[TBL] [Abstract][Full Text] [Related]
6. Enhancing effects of morphine on methamphetamine-induced reinforcing behavior and its association with dopamine release and metabolism in mice.
Lan KC; Chang AC; Liu SH; Ho IK; Lin-Shiau SY
J Neurochem; 2009 Apr; 109(2):382-92. PubMed ID: 19245664
[TBL] [Abstract][Full Text] [Related]
7. Dual alteration of limbic dopamine D1 receptor-mediated signalling and the Akt/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization.
Chen PC; Lao CL; Chen JC
J Neurochem; 2007 Jan; 100(1):225-41. PubMed ID: 17101033
[TBL] [Abstract][Full Text] [Related]
8. Chronic benzylpiperazine (BZP) exposure produces behavioral sensitization and cross-sensitization to methamphetamine (MA).
Brennan K; Johnstone A; Fitzmaurice P; Lea R; Schenk S
Drug Alcohol Depend; 2007 May; 88(2-3):204-13. PubMed ID: 17125936
[TBL] [Abstract][Full Text] [Related]
9. (+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administration.
Gentry WB; Ghafoor AU; Wessinger WD; Laurenzana EM; Hendrickson HP; Owens SM
Pharmacol Biochem Behav; 2004 Dec; 79(4):751-60. PubMed ID: 15582684
[TBL] [Abstract][Full Text] [Related]
10. Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration.
Rivière GJ; Gentry WB; Owens SM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1042-7. PubMed ID: 10688621
[TBL] [Abstract][Full Text] [Related]
11. Development of a home cage locomotor tracking system capable of detecting the stimulant and sedative properties of drugs in rats.
Dunne F; O'Halloran A; Kelly JP
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1456-63. PubMed ID: 17706334
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the behavioural responses induced by chronic administration of methamphetamine and amphetamine in mice.
Peachey JE; Rogers B; Brien JF
Psychopharmacology (Berl); 1977 Jan; 51(2):137-40. PubMed ID: 402664
[TBL] [Abstract][Full Text] [Related]
13. Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization.
Segal DS; Kuczenski R
J Pharmacol Exp Ther; 1997 Aug; 282(2):561-73. PubMed ID: 9262316
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine-elicited alterations of dopamine- and serotonin-metabolite levels within mu-opioid receptor knockout mice: a microdialysis study.
Lan KC; Ma T; Lin-Shiau SY; Liu SH; Ho IK
J Biomed Sci; 2008 May; 15(3):391-403. PubMed ID: 17934798
[TBL] [Abstract][Full Text] [Related]
15. Behavioral, toxic, and neurochemical effects of sydnocarb, a novel psychomotor stimulant: comparisons with methamphetamine.
Witkin JM; Savtchenko N; Mashkovsky M; Beekman M; Munzar P; Gasior M; Goldberg SR; Ungard JT; Kim J; Shippenberg T; Chefer V
J Pharmacol Exp Ther; 1999 Mar; 288(3):1298-310. PubMed ID: 10027871
[TBL] [Abstract][Full Text] [Related]
16. The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats.
Tsukamoto T; Iyo M; Tani K; Sekine Y; Hashimoto K; Ohashi Y; Suzuki K; Iwata Y; Mori N
Psychopharmacology (Berl); 2001 Nov; 158(2):107-13. PubMed ID: 11702083
[TBL] [Abstract][Full Text] [Related]
17. Incorporation and retention of radiolabeled S-(+)-and R-(-)-methamphetamine and S(+)- and R(-)-N-(n-butyl)-amphetamine in mouse hair after systemic administration.
Stout PR; Claffey DJ; Ruth JA
Drug Metab Dispos; 2000 Mar; 28(3):286-91. PubMed ID: 10681372
[TBL] [Abstract][Full Text] [Related]
18. (-)Deprenyl (selegiline) is devoid of amphetamine-like behavioural effects in rats.
Tímár J; Knoll B; Knoll J
Acta Physiol Hung; 1992; 79(2):131-7. PubMed ID: 1363925
[TBL] [Abstract][Full Text] [Related]
19. [Comparative pharmacological effects of dl-amphetaminil and dl-amphetamine in the rat].
Fernandes M; Coper H; Honecker H
Arzneimittelforschung; 1976 Feb; 26(2):253-8. PubMed ID: 947209
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat.
Rivière GJ; Byrnes KA; Gentry WB; Owens SM
J Pharmacol Exp Ther; 1999 Dec; 291(3):1220-6. PubMed ID: 10565845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
